← Leaderboards
Martin Rhys Farlow
Indiana Univ-Purdue Univ At Indianapolis
$7,840,800
Attributed
$12,106,757
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,106,757 · 4
By mechanism
R01$6,398,936 · 1
P30$5,707,821 · 2
M01$0 · 1
Top collaborators
- Neil W. Kowall5 shared
- Wei Qiao Qiu5 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mary G Austrom$2,883,907
- Tatiana M. Foroud$164,603,187
- Andrew P Evan$8,831,253
- Susanne Ragg$969,191
- P. Michael Conneally$3,181,097
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPlasmaDementiaAfrican AmericanClinical ResearchCerebrospinal FluidSamplingDiagnosisS DiseaseMild Cognitive ImpairmentAlzheimer'S DiseaseBiomarkerHuman SubjectPatient CareFamily GeneticsPhenotypeNeuropharmacologyGenotypeNeuropsychologyBiomedical FacilityDiagnosis Design /EvaluationDisease /Disorder Proneness /RiskBiological MarkersBrain Disorder Diagnosis
Grant awards (27)
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,266,625
R01 · FY2022 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2021 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2020 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2019 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,306,078
R01 · FY2018 · AG
Clinical Core$608,245
P30 · FY2015 · AG · contact PI
Clinical Core$527,015
P30 · FY2014 · AG · contact PI
Clinical Core$497,749
P30 · FY2013 · AG · contact PI
CORE--CLINICAL$784,652
P30 · FY2010 · AG · contact PI
CORE--CLINICAL$772,980
P30 · FY2009 · AG · contact PI
CORE--CLINICAL$620,024
P30 · FY2008 · AG · contact PI
CORE--CLINICAL$615,587
P30 · FY2007 · AG · contact PI
CORE--CLINICAL$330,507
P30 · FY2006 · AG · contact PI
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2002 · RR
CORE-- CLINICAL$0
P30 · FY2001 · AG
CORE-- CLINICAL$0
P30 · FY2001 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2001 · RR
CORE-- CLINICAL$236,994
P30 · FY2000 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR